Please login to Zacks.com or register to post a comment.
| No Recent Quote currently available |
|
My Portfolio Tracker One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts. Set yours up today. |
Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.
Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.
Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.
My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.
| Company Name | Symbol | %Change |
|---|---|---|
| SCIENTIFIC L | SCIL | 8.00% |
| NATUS MEDICA | BABY | 6.11% |
| SUMMER INFAN | SUMR | 6.02% |
| RADIANT LOGI | RLGT | 5.32% |
| NEW ORIENTAL | EDU | 4.51% |
Please login to Zacks.com or register to post a comment.
Resources
Client Support
Zacks Research is Reported On:
Zacks Investment Research
is an A+ Rated BBB
Accredited Business.
Copyright 2013 Zacks Investment Research
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1986 it has nearly tripled the S&P 500 with an average gain of +26% per year. These returns cover a period from 1986-2011 and were examined and attested by Baker Tilly, an independent accounting firm.
Visit performance for information about the performance numbers displayed above.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This page is temporarily not available. Please check later as it should be available shortly. If you have any questions, please email customer support at support@zacks.com or call 800-767-3771 ext. 9339.
Energy major Chevron Corp. ( CVX - Analyst Report ) has purchased 50% interest in Lithuanian oil and gas exploration company, LL Investicijos. Details pertaining to the agreement were not disclosed by the company.
According to Chevron, it will begin exploration work in the coming months. The company believes that there is a significant accumulation of extractable shale gas in a belt that stretches from the Baltic countries to the Mediterranean.
Currently, Lithuania is fully dependent on Russia for natural gas supply and is also involved in a clash with Gazprom (Russia’s oil giant) over pricing. However, in order to gain energy independence, the country is trying to extend its local resources.
We see Chevron’s stake buy in Lithuania as a clear sign of its increasing interest in European unconventional natural gas. Chevron has already purchased about 4 million acres of exploration acreage in Poland and Romania. The company is also looking at a production-sharing agreement with Ukraine. Chevron has already drilled two wells in Poland and plans to start work on another.
It is expected that Chevron will increase its stake in Lithuania in the coming years.
San Ramon, California-based Chevron displays a strong portfolio of global projects, targeting volume growth of around 20% by 2017. Additionally, Chevron possesses one of the healthiest balance sheets among its peers – which include BP plc ( BP - Analyst Report ) , ExxonMobil Corp. ( XOM - Analyst Report ) and Royal Dutch Shell plc ( RDS.A - Analyst Report ) – that helps it to capitalize on investment opportunities with the option to make strategic acquisitions.
Management made significant progress in re-balancing Chevron’s asset portfolio by divesting non-core and high-cost assets. The company’s decision to sell its marketing businesses in Kenya, Nigeria, Uganda, Western Africa and Brazil is part of that strategy. In particular, Chevron plans to exit the low profit generating business and concentrate on the discovery of oil and gas worldwide.
However, Chevron’s production growth profile depends on the timely development of upstream projects, almost all of which have inherent risk factors. Time and cost overruns on these programs may lead to lower returns going forward.
As such, we see the stock performing in line with the broader market and maintain our long-term Neutral recommendation, supported by a Zacks #3 Rank (short-term Hold rating).
Read the full Analyst Report on BP
Read the full Analyst Report on CVX
Read the full Analyst Report on RDS.A
Read the full Analyst Report on XOM